Beneficial response to anakinra and thalidomide in Schnitzler's syndrome
about
Schnitzler's syndrome: lessons from 281 casesThe challenge of autoinflammatory syndromes: with an emphasis on hyper-IgD syndromeBiologics in dermatologic therapy - an update.Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases.Why not treat human cancer with interleukin-1 blockade?Schnitzler syndrome with cold-induced urticariaThe histone deacetylase inhibitor ITF2357 reduces production of pro-inflammatory cytokines in vitro and systemic inflammation in vivoEffects of the histone deacetylase inhibitor ITF2357 in autoinflammatory syndromes.Pharmacokinetics, safety and inducible cytokine responses during a phase 1 trial of the oral histone deacetylase inhibitor ITF2357 (givinostat).Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey.An expanding role for interleukin-1 blockade from gout to cancer.Autoinflammation: translating mechanism to therapy.Therapy of autoinflammatory syndromes.The role of interleukin-1 beta in the pathophysiology of Schnitzler's syndrome.The spectrum of autoinflammatory diseases: recent bench to bedside observationsCytokine inhibition in chronic fatigue syndrome patients: study protocol for a randomized controlled trial.Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases.Schnitzler's syndrome: successful treatment with anakinra.Autoinflammatory syndromes with a dermatological perspective.Schnitzler's syndrome: a case report.Schnitzler syndrome: an under-diagnosed clinical entity.The Central Role of Anti-IL-1 Blockade in the Treatment of Monogenic and Multi-Factorial Autoinflammatory Diseases.NOD-like receptors and inflammation.Treating inflammation by blocking interleukin-1 in humans.Inflammasome and IL-1beta-mediated disordersRegulation of inflammasome activity.Treatment of Schnitzler's syndrome with anakinra: report of three cases and review of the literature.Cryopyrin-associated periodic syndrome: an update on diagnosis and treatment response.Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1.Pattern recognition receptors in immune disorders affecting the skin.Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome.Time-course analysis of serum hepcidin, iron and cytokines in a C282Y homozygous patient with Schnitzler's syndrome treated with IL-1 receptor antagonist.A rare cause of a common symptom, Anakinra is effective in the urticaria of Schnitzler Syndrome: a case report.Mullins' syndrome: a new gammopathy-related autoinflammatory syndrome resistant to anakinraSchnitzler's syndrome: a diagnostic conundrum.Anakinra in the treatment of rheumatic disease.Dysfunctional inflammasome in Schnitzler's syndrome.Kidney involvement in the Schnitzler syndrome, a rare disease.An integrated classification of pediatric inflammatory diseases, based on the concepts of autoinflammation and the immunological disease continuum.
P2860
Q21195864-4F7164A4-25C6-4B99-B010-EFDC40677F84Q28070297-D0519B85-5D84-40BB-9C61-2FC68882ED26Q33607620-3F90657E-27F7-47F2-8895-CC82F36687BFQ33710807-46022F54-8936-4685-874A-CCF1727AA888Q33833871-12DA34AE-E847-41B7-9396-836E5D116268Q34212996-DCC89FD0-4CC8-450F-B66B-8DC389DC1DD0Q34504770-DA1558AB-F3B8-4667-8336-5825C7778942Q35016951-5623AE07-73D3-42C4-9254-ED78F8B0B045Q35016969-478F8D82-F089-4264-86A5-B469772B5B8FQ35122583-DE780408-68FB-44FD-BE9A-93BD24CBA236Q35219001-BB22E2A3-CEE1-4BA0-9E28-4D88B0FFA249Q35558406-B3C99287-F491-4758-858A-90BAA227A725Q35868028-DEC19461-D121-4079-8F01-6AA61B78AB3DQ35879125-0B095088-C36C-45D5-A790-A75240636317Q36048259-F3A07AA5-3A15-4940-A554-7B71A7B427A6Q36126508-0DAF17C1-C98F-43D3-8C4B-6F72231495ACQ36816872-51DF2A47-08CD-4CAA-AFB9-58F2A1AFE1EBQ36903081-34F93FC7-ACBE-4359-B080-D33A18F91DC7Q36922302-023E8D9A-D5F4-49E6-8446-3DE0A676C5FDQ36949902-95CF982B-0519-4279-8D27-CCB3AFA9C47AQ37212707-9327AADF-EFFB-45DA-B8D0-E837310CA483Q37270409-D5CFFC02-8CB8-47BA-89E3-760255676545Q37353179-7FC48B32-BBC1-407E-9A92-07847FA51E93Q37636664-5C1C257A-5619-426A-9DAF-7A74C04E605FQ37738096-35B6406B-4D52-470D-A324-B75F7CB4669FQ37750913-AE39876E-188D-4AE6-8868-7769CB93B5E8Q37799379-5031BCC0-52BF-4C5D-8ACC-7717D33E12FEQ37811988-E6F71DA0-3BC1-4A5F-9358-2392A67EAECCQ37979862-F904F33F-9469-4CA7-8C5E-4F2504C54FADQ37991471-E2765421-E7C8-4FA6-9F9D-FD06988B80EEQ40270754-6EECD00E-E32C-450C-BAC8-3DE88CAE4FDAQ40384524-5981A47A-2A74-4BB4-81BE-BFB6D3B1E959Q40404340-93E644B2-0AA5-4910-A1A1-2CCF5E35AE2EQ41210551-D711C29D-33A4-4284-8D1F-60D202DB2ECFQ42717455-22FC8EEF-7785-4F09-8CAE-E5328C88B2FAQ43061720-F1A8E0C6-C546-4C24-A3D2-CD4F81464B4BQ43288641-75E14521-6F21-47AE-A001-4D24ACB1F0FCQ49294603-B749F403-C17F-4177-ABE0-2104ADA795C3Q52850152-87EB8011-2794-44C2-99D2-7301F61B393D
P2860
Beneficial response to anakinra and thalidomide in Schnitzler's syndrome
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Beneficial response to anakinra and thalidomide in Schnitzler's syndrome
@ast
Beneficial response to anakinra and thalidomide in Schnitzler's syndrome
@en
Beneficial response to anakinra and thalidomide in Schnitzler's syndrome
@nl
type
label
Beneficial response to anakinra and thalidomide in Schnitzler's syndrome
@ast
Beneficial response to anakinra and thalidomide in Schnitzler's syndrome
@en
Beneficial response to anakinra and thalidomide in Schnitzler's syndrome
@nl
prefLabel
Beneficial response to anakinra and thalidomide in Schnitzler's syndrome
@ast
Beneficial response to anakinra and thalidomide in Schnitzler's syndrome
@en
Beneficial response to anakinra and thalidomide in Schnitzler's syndrome
@nl
P2093
P2860
P356
P1476
Beneficial response to anakinra and thalidomide in Schnitzler's syndrome
@en
P2093
H D de Koning
J C H van der Hilst
J W M van der Meer
P2860
P304
P356
10.1136/ARD.2005.045245
P407
P50
P577
2005-08-11T00:00:00Z